Cite
HARVARD Citation
Prazuck, T. et al. (2021). Tenofovir disoproxil fumarate and emtricitabine maintenance strategy in virologically controlled adults with low HIV-1 DNA: 48 week results from a randomized, open-label, non-inferiority trial. Journal of antimicrobial chemotherapy. pp. 1564-1572. [Online].